Tuesday, June 21 4:00pm - 5:30pm
Room 204
Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of US-based, pre-series A-funded, therapeutic Biotech companies.
Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants.
Agenda
There’s nothing that comes close to hearing the honest advice and experience of peers treading the same path as you. LSX’s CEO Forums offer executives the chance to exchange ideas with and seek advice from peers in a private group setting. They are an opportunity to share learnings, best practice and some great thinking, as well as meeting other influential people to support your business journey. Capped at 20 participants, the forums operate under strict Chatham House Rule.
4:00pm Opening remarks and introductions
4:05pm Efficient and Effective IP Due Diligence
Attracting investment, licensing opportunities, and partnerships is often of paramount importance to many companies. In industries where intellectual property (IP) constitutes the bulk of a company’s value, the strength of its patent portfolio can make or break its prospects for continued success. When millions of dollars or even entire businesses are at stake, IP due diligence is essential to determining the full value of the IP involved, assessing and evaluating the risks, and determining whether the transaction is in each party’s best interests.
Gwilym Attwell, Principal, Fish & Richardson
4:20pm Q&A
4:30pm Designing a Development Strategy to Maximize Early Exit
Robb Lawrence, SVP, Commercial Strategy Solutions, Premier Consulting
4:45pm Q&A
4:55pm How to make a splash in Biotech – strategic partnering and fundraising routes
Judy Chou, CEO and President, AltruBio, Inc.
5:05pm General Discussion (suggested topics to include but not limited to)
5:30pm Wrap-up
Co-hosts:
